BACKGROUND AND OBJECTIVES: Depression is a risk indicator for adverse outcomes in dialysis patients, but its prognostic impact in individuals who are not yet on dialysis is unknown. This study examines whether depressive symptoms are longitudinally associated with renal function decline, new-onset chronic kidney disease (CKD), ESRD, or hospitalization with acute kidney injury (AKI). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Depressive symptoms were measured in a longitudinal cohort study with the 10-item Centers for Epidemiologic Studies Depression scale using a previously validated cut-off value (≥8). CKD at study entry and during follow-up was defined as an estimated GFR (eGFR) < 60 ml/min per m(2). Outcomes were rapid decline in eGFR (>3 ml/min per m(2) per year), new-onset CKD, ESRD (U.S. Renal Data System-based), and AKI (based on adjudicated medical record review). The median follow-up duration was 10.5 years. RESULTS: Depressed participants (21.2%) showed a higher prevalence of CKD at baseline compared with nondepressed participants in multivariable analysis. Depression was associated with a subsequent risk of rapid decline in eGFR, incident ESRD, and AKI, but not incident CKD in unadjusted models. In multivariable analyses, only associations of depressive symptoms with AKI remained significant. CONCLUSIONS: Elevated depressive symptoms are associated with subsequent adverse renal disease outcomes. The depression-related elevated risk of AKI was independent of traditional renal disease risk factors and may in part be explained by the predictive value of depression for acute coronary syndromes and heart failure hospitalizations that can be complicated by AKI.
BACKGROUND AND OBJECTIVES:Depression is a risk indicator for adverse outcomes in dialysis patients, but its prognostic impact in individuals who are not yet on dialysis is unknown. This study examines whether depressive symptoms are longitudinally associated with renal function decline, new-onset chronic kidney disease (CKD), ESRD, or hospitalization with acute kidney injury (AKI). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Depressive symptoms were measured in a longitudinal cohort study with the 10-item Centers for Epidemiologic Studies Depression scale using a previously validated cut-off value (≥8). CKD at study entry and during follow-up was defined as an estimated GFR (eGFR) < 60 ml/min per m(2). Outcomes were rapid decline in eGFR (>3 ml/min per m(2) per year), new-onset CKD, ESRD (U.S. Renal Data System-based), and AKI (based on adjudicated medical record review). The median follow-up duration was 10.5 years. RESULTS: Depressed participants (21.2%) showed a higher prevalence of CKD at baseline compared with nondepressed participants in multivariable analysis. Depression was associated with a subsequent risk of rapid decline in eGFR, incident ESRD, and AKI, but not incident CKD in unadjusted models. In multivariable analyses, only associations of depressive symptoms with AKI remained significant. CONCLUSIONS:Elevated depressive symptoms are associated with subsequent adverse renal disease outcomes. The depression-related elevated risk of AKI was independent of traditional renal disease risk factors and may in part be explained by the predictive value of depression for acute coronary syndromes and heart failure hospitalizations that can be complicated by AKI.
Authors: Antonio Alberto Lopes; Jennifer Bragg; Eric Young; David Goodkin; Donna Mapes; Christian Combe; Luis Piera; Philip Held; Brenda Gillespie; Friedrich K Port Journal: Kidney Int Date: 2002-07 Impact factor: 10.612
Authors: Roland von Känel; Brent T Mausbach; Joel E Dimsdale; Paul J Mills; Thomas L Patterson; Sonia Ancoli-Israel; Michael G Ziegler; Susan K Roepke; Elizabeth A Chattillion; Matthew Allison; Igor Grant Journal: Psychosom Med Date: 2012-01-27 Impact factor: 4.312
Authors: Margaret K Yu; Noel S Weiss; Xiaobo Ding; Wayne J Katon; Xiao-Hua Zhou; Bessie A Young Journal: Clin J Am Soc Nephrol Date: 2014-03-27 Impact factor: 8.237
Authors: C Barrett Bowling; John N Booth; Orlando M Gutiérrez; Manjula Kurella Tamura; Lei Huang; Meredith Kilgore; Suzanne Judd; David G Warnock; William M McClellan; Richard M Allman; Paul Muntner Journal: Clin J Am Soc Nephrol Date: 2014-10-02 Impact factor: 8.237
Authors: Georica K Gholson; Denée T Mwendwa; Regina Sims Wright; Clive O Callender; Alfonso L Campbell Journal: Ethn Dis Date: 2015 Impact factor: 1.847
Authors: Michael J Fischer; Dawei Xie; Neil Jordan; Willem J Kop; Marie Krousel-Wood; Manjula Kurella Tamura; John W Kusek; Virginia Ford; Leigh K Rosen; Louise Strauss; Valerie L Teal; Kristine Yaffe; Neil R Powe; James P Lash Journal: Am J Kidney Dis Date: 2012-04-11 Impact factor: 8.860
Authors: Farrukh M Koraishy; Steven G Coca; Beth E Cohen; Jeffery F Scherrer; Frank Mann; Pei-Fen Kuan; Benjamin J Luft; Sean A P Clouston Journal: Psychosom Med Date: 2021 Nov-Dec 01 Impact factor: 4.312